TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Key Cancer Legislation Remains Unfinished as Congress Departs for Election. October 6, 2006
TCL Archive Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock. March 11, 2005
TCL Archive MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building. May 12, 2006
TCL Archive NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants February 23, 1996
